Literature DB >> 23967375

Clopidogrel (Plavix) could have a negative effect on bone health.

.   

Abstract

Entities:  

Year:  2012        PMID： 23967375      PMCID： PMC3727774          DOI： 10.1038/bonekey.2012.172

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  1 in total

1.  Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo.

Authors:  Susanne Syberg; Andrea Brandao-Burch; Jessal J Patel; Mark Hajjawi; Timothy R Arnett; Peter Schwarz; Niklas R Jorgensen; Isabel R Orriss
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741
  1 in total
  1 in total

1.  Therapeutic doses of clopidogrel increase fracture risk.

Authors: 
Journal:  Bonekey Rep       Date:  2012-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.